Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Alzheimer'S Research & Therapy|July 8, 2018
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristicsIsabelle Bos, Stephanie Vos, Rik Vandenberghe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2023
Contributions of amyloid beta and cerebral small vessel disease in clinical declineJustine E F Moonen, Renée Haan, Isabelle Bos, et al.
Alzheimer'S Research & Therapy|June 22, 2018
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive declineIsabelle Bos, Frans R Verhey, Inez H G B Ramakers, et al.
Alzheimer'S Research & Therapy|December 30, 2017
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive declineIsabelle Bos, Frans R Verhey, Inez H G B Ramakers, et al.
Research Square|August 7, 2024
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 16, 2022
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognitionKirsten E J Wesenhagen, Johan Gobom, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotypeLisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Pageof 6